Please login to the form below
diversity
This page shows the latest diversity news and features for those working in and with pharma, biotech and healthcare.
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
The beauty of the omnichannel landscape is its diversity. If we want to maximise the channels our customers favour, content must be differential and designed to exploit the specific benefits individual
Latest news
-
The key to unlocking inclusivity is continual learning
our diversity, equity and inclusion (DE&I) initiatives.
-
Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
While we were hoping for a stronger interim outcome, we recognise that demonstrating high efficacy in this unprecedented broad diversity of variants is challenging,” said Franz-Werner Haas, chief executive officer
-
Sense of belonging
As we enhance our focus on diversity, inclusion and equity, this will also enhance the feeling of belonging.
-
Q&A: Sarah Gordon
Who is your healthcare comms hero/heroine? My first healthcare comms job was working for Margot James, one of the trailblazers for women and diversity in our industry.
-
Responsibly growing our talent pool
If we are looking at universities, then let’s at least look beyond the top universities where diversity is already diminished. ... Driving diversity. Many organisations talk about their desire to embrace diversity and create more diverse, equitable and
The key to unlocking inclusivity is continual learning
Disappointing results from CureVac’s COVID-19 vaccine as phase 2/3 study shows only 47% efficacy
Sense of belonging
Q&A: Sarah Gordon
Responsibly growing our talent pool
More from news
Approximately 3 fully matching, plus 144 partially matching documents found.
Latest Intelligence
-
The future of work has been just around the corner for some time...
As mindsets shift, expectations change and diversity in thinking becomes ever more important; we need to remain agile.
-
Patient diversity in clinical trials needs to be centre stage
lack of diversity in clinical trials by building evidence and amplifying patient voices. ... The time is right that equality and diversity are enshrined in everything we do but particularly in clinical trials.
-
Your clinical trial participants are precious, so treat them as such
By Su Smith. Taking part in a clinical trial is a selfless act towards improving healthcare, right? Or it’s a person’s last resort when licensed therapies are unavailable or ineffective. This last year with COVID-19 has clearly demonstrated that
-
Diversity and inclusion in clinical trials
ways, the FDA guidance issued in November that addressed the multidimensional aspects of diversity and inclusion in clinical trials, and the coverage of social unrest with the demand for equity featured ... ICON is due to release a white paper on
-
Why we need to look beyond cultural competency to fix the patient diversity challenge
The lack of diversity in clinical research is a concerning issue, and the debate on how best to improve diversity in clinical trials is not a new one. ... Whether the training is used to impact study and protocol design, improve patient recruitment
The future of work has been just around the corner for some time...
Patient diversity in clinical trials needs to be centre stage
Your clinical trial participants are precious, so treat them as such
Diversity and inclusion in clinical trials
Why we need to look beyond cultural competency to fix the patient diversity challenge
More from intelligence
Approximately 7 fully matching, plus 55 partially matching documents found.
Latest appointments
-
Paula Hensler joins Havas Just:: as scientific director
This is an exciting phase for scientific communicators. Post pandemic there is a spotlight on health inequalities and diversity.
-
Syneos Health Communications announces senior hires to Europe-based team
Most recently, she set up the internal and external diversity, equity and inclusion (DE&I) offering for a major medical education agency.
-
Evoke KYNE promotes Michael Grela to head of reputation and social impact
Grela will partner with Evoke KYNE’s leadership to highlight the agency’s Diversity, Equity and Inclusion efforts externally.
-
Ex-J&J exec Denice Torres joins bluebird bio’s board
In addition, she has a deep understanding of the benefit of cultivating people, diversity and culture to strengthen internal collaboration and propel companies forward.
-
Aurora boosts team with new hires and internal promotions
He has authored Aurora’s reports on collaboration in healthcare, was instrumental to the agency’s award-winning gender diversity work in 2019 and has engaged a wide range of public
Paula Hensler joins Havas Just:: as scientific director
Syneos Health Communications announces senior hires to Europe-based team
Evoke KYNE promotes Michael Grela to head of reputation and social impact
Ex-J&J exec Denice Torres joins bluebird bio’s board
Aurora boosts team with new hires and internal promotions
More from appointments
Approximately 0 fully matching, plus 17 partially matching documents found.
Latest from PMHub
-
Day in the life of an emotive Art Director
This diversity is one of the main things that I love about emotive – it never gets boring! .
-
How do ethnic minority groups in the U.S. view clinical trials?
The Demand Diversity research found that there are two key themes that contributed to medical mistrust — unequal treatment and money. ... Moving forward, we must rectify medical mistrust and form trustworthy relationships with these communities, as
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
collaboration and need for ethnic diversity in clinical trials. ... Biopharma Reporter.
-
Understanding the authentic patient experience can redefine the success of your clinical trial before you design it
This month’s edition of PME features a number of articles and opinion pieces on diversity and inclusion in clinical trials.
-
Include Us All in Your Clinical Trials
44 (0) 330 995 0656. Address:. Suite 2.10, Jactin House. 24 Hood Street. Manchester. M4 6WX. United Kingdom.
How do ethnic minority groups in the U.S. view clinical trials?
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
Understanding the authentic patient experience can redefine the success of your clinical trial before you design it
More from PMHub
Approximately 51 fully matching, plus 54 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Digital strategist
-
Competitive
-
Digital account director
-
Competitive
-
Digital project manager
-
Competitive
- FREELANCE (Outside IR35) Opportunities for this week below!!!
-
Superb Day Rate
- Client Services Director +, Remote or London – Leadership Opport...
-
Highly Competitive Salary, Bonus &Benefits
- Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
- Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- GSK reveals plans for £400m R&D facility expansion in England
- bluebird bio to restart marketing of Zynteglo in EU after previous suspension
- FDA leaders offer perspective on accelerated approval of Biogen’s Aduhelm
- Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The future of work has been just around the corner for some time...
- Investigating the Complexities of the Canadian & Global Health Systems
- Impetus Digital Overview
- FDA advisory committee votes against approval of AZ, FibroGen's roxadustat
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med
- Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
- Merck & Co's cancer drug Keytruda gaining traction in US
PMHub
Aurora Healthcare Communications
We're a leading healthcare strategic communications agency helping pharmaceutical companies adapt fast to improve the lives of patients and healthcare...
Latest intelligence
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
- The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
- Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
- Virtual Speaker Program: A Customer Story
- Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....
